Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes

Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes

US Patent 12110504 · Granted Oct 8, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2025
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2025
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2025
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2025
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2025
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2025
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2024
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2024
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2024
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2024
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2024
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically co2024